Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one
Peterson, Gregory M, Thomas, Jackson, Yee, Kwang C, Kosari, Sam, Naunton, Mark and Olesen, Inger H 2018, Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one, Journal of clinical pharmacy and therapeutics, vol. 43, no. 6, pp. 925-930, doi: 10.1111/jcpt.12750.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.